GTS Securities’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-887
Closed -$252K 1750
2025
Q4
$252K Buy
887
+207
+30% +$64.7K 0.01% 1159
2025
Q3
$210K Buy
+680
New +$213K 0.01% 1262
2024
Q4
Sell
-1,604
Closed -$373K 3324
2024
Q3
$373K Buy
+1,604
New +$329K ﹤0.01% 3103
2024
Q1
Sell
-1,160
Closed -$252K 4296
2023
Q4
$252K Buy
+1,160
New +$199K ﹤0.01% 3370

Other funds holding PODD

GTS Securities's PODD Position: Q1 2026 in Review

GTS Securities sold out of Insulet (PODD) in Q1 2026, closing a stake of 887 shares — an estimated $252K sold.

GTS Securities first reported a position in PODD in Q4 2023 and held it in 4 quarters. The position peaked at $373K in Q3 2024. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • GTS Securities reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 887 Insulet shares in Q1 2026, an estimated $252K.
  • GTS Securities first reported a position in Insulet in Q4 2023 and held it in 4 quarters.
  • GTS Securities's Insulet position peaked at $373K in Q3 2024.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.